Prosecution Insights
Prosecution Insights
57 pending office actions • 38 clients • 54 examiners • 41 art units • 0 of 57 (0%) have an AI response strategy ready • 67 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 26 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 26 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §103 only | 32 (56%) |
| §102 only | 8 (14%) |
| §112 only | 8 (14%) |
| Double-patenting only | 3 (5%) |
| No statute on record | 5 (9%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRAUN, MADELINE E | 2 | 68.1% | +25.2% |
| HABTE, KAHSAY | 2 | 85.0% | +7.4% |
| LEE, JAE W | 2 | 65.5% | +38.9% |
| FAN, WEIHUA | 1 | 83.1% | +12.2% |
| MONSHI, SAMIRA | 1 | 80.0% | +6.0% |
| BLACK-CHILDRESS, RAJSHEED O | 1 | 62.5% | +24.4% |
| KIEFER, DALTON EDWARD | 1 | — | — |
| VIGIL, TORIANA NICHOLE | 1 | 51.9% | +19.2% |
| KOMATSU, LI N | 1 | 59.7% | +71.0% |
| BONZELL, PHILIP J | 1 | 78.4% | +12.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253916 | SMALL MOLECULE INHIBITOR FOR CATHEPSIN C AND MEDICINAL USE THEREOF | HABTE, KAHSAY | 17d overdue |
| 18994130 | MULTI-SENSOR FOR INTRUSION DETECTION FENCE | MONSHI, SAMIRA | 15d |
| 19125664 | EPISTATIC TOMATO QTLS FOR INCREASING YIELD | FAN, WEIHUA | — |
| 18554199 | THERAPEUTIC MODALITIES FOR INHIBITING PANCREATIC BETA CELL IMPAIRMENT AND TREATING DIABETES | HABTE, KAHSAY | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18326837 | AUTOANTIBODIES, KITS AND METHODS OF VERIFYING THE ACCURACY OF DIAGNOSTIC RESULTS | LIRIANO-NG, MELISSA LIZETTE | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18762553 | SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF | KOMATSU, LI N | 23d overdue |
| 18040810 | CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING | LEE, JAE W | 15d |
| 19125664 | EPISTATIC TOMATO QTLS FOR INCREASING YIELD | FAN, WEIHUA | — |
| 18886876 | HIGH-ALTITUDE BALLOON PAYLOAD WITH ATTITUDE CONTROL AND PREDICTIVE SCHEDULING, FOR AEROBIOLOGICAL SAMPLING AND ENVIRONMENTAL MONITORING | BLACK-CHILDRESS, RAJSHEED O | — |
| 18801052 | METHOD OF TREATING OBESITY BY SELECTIVE TARGETING OF VISCERAL ADIPOSITY USING POLYCATION NANOMEDICINE | VIGIL, TORIANA NICHOLE | — |
| 18836748 | POLYMORPH AS THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF | BRAUN, MADELINE E | — |
| 18744407 | BATTERY-POWERED, TEMPERATURE-CONTROLLED DEVICES AND METHODS FOR TRANSPORT, STORAGE, AND EXPERIMENTATION IN MICRO-GRAVITY RESEARCH AND MANUFACTURING APPLICATIONS | BONZELL, PHILIP J | — |
| 17905583 | IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING | LEE, JAE W | — |
| Art Unit | Apps |
|---|---|
| 1656 | 3 |
| 1624 | 3 |
| 1678 | 3 |
| 1658 | 2 |
| 1631 | 2 |
| 1628 | 2 |
| 1672 | 2 |
| 1663 | 1 |
| 2422 | 1 |
| 2685 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19125664 | EPISTATIC TOMATO QTLS FOR INCREASING YIELD | Yissum Research Development Company Of The Hebrew University Of Jerusalem Lt | FAN, WEIHUA | 1663 | §112 | Non-Final OA | — | Pending | Apr 29, 2025 |
| 18994130 | MULTI-SENSOR FOR INTRUSION DETECTION FENCE | Senstar Corporation | MONSHI, SAMIRA | 2422 | §103 | Non-Final OA | 15d | Pending | Jan 14, 2025 |
| 18886876 | HIGH-ALTITUDE BALLOON PAYLOAD WITH ATTITUDE CONTROL AND PREDICTIVE SCHEDULING, FOR AEROBIOLOGICAL SAMPLING AND ENVIRONMENTAL MONITORING | Arizona Board of Regents | BLACK-CHILDRESS, RAJSHEED O | 2685 | §103 | Final Rejection | — | Pending | Sep 16, 2024 |
| 18819967 | METHODS AND COMPOSITIONS TO REGULATE MAPT SPLICING FOR MODELING AND TREATMENT OF TAUOPATHIES | The Trustees of Columbia University in the City of New York | KIEFER, DALTON EDWARD | §103 | Non-Final OA | — | Pending | Aug 29, 2024 | |
| 18801052 | METHOD OF TREATING OBESITY BY SELECTIVE TARGETING OF VISCERAL ADIPOSITY USING POLYCATION NANOMEDICINE | The Trustees of Columbia University in the City of New York | VIGIL, TORIANA NICHOLE | — | Non-Final OA | — | Pending | Aug 12, 2024 | |
| 18836748 | POLYMORPH AS THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF | Xizang Haisco Pharmaceutical Co., Ltd. | BRAUN, MADELINE E | §102 | Non-Final OA | — | Pending | Aug 07, 2024 | |
| 18762553 | SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF | Arizona Board of Regents | KOMATSU, LI N | 1658 | §112 | Final Rejection | 23d overdue | Pending | Jul 02, 2024 |
| 18744407 | BATTERY-POWERED, TEMPERATURE-CONTROLLED DEVICES AND METHODS FOR TRANSPORT, STORAGE, AND EXPERIMENTATION IN MICRO-GRAVITY RESEARCH AND MANUFACTURING APPLICATIONS | Ambassador Asset Management Limited Partnership | BONZELL, PHILIP J | §103 | Non-Final OA | — | Pending | Jun 14, 2024 | |
| 18676295 | SYSTEM AND METHOD FOR DRY BATTERY ELECTRODE FABRICATION VIA DIRECT POWDER BED FORMATION AND COMPRESSION | Arizona Board of Regents | TALBOT, BRIAN K | 1712 | §103 | Non-Final OA | 31d overdue | Pending | May 28, 2024 |
| 18701580 | SYSTEM FOR DETECTING AND/OR ASSESSING A SUBDURAL HEMATOMA | Yeda Research And Development Co. Ltd. | AKAR, SERKAN | 3797 | §103 | Non-Final OA | 10d overdue | Pending | Apr 15, 2024 |
| 18685882 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | RZECZYCKI, PHILLIP MATTHEW | 1625 | DP | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18293759 | PROCESS FOR PRODUCING RECYCLED LACTATE SALT | Triplew Ltd. | CUTLIFF, YATE KAI RENE | §103 | Non-Final OA | — | Pending | Jan 30, 2024 | |
| 18291554 | TOOL FOR CONTINUOUS INSERTION-DEPTH MONITORING FOR IMPLANTABLE LEAD | UNIVERSITEIT ANTWERPEN | PATEL, NIKETA I | 3792 | §103 | Non-Final OA | 38d overdue | Pending | Jan 23, 2024 |
| 18415537 | ANTIMICROBIAL SOLUTIONS AND USES THEREOF | Ecoplanet Environmental LLC | MORNHINWEG, JEFFREY P | 1793 | §103 | Non-Final OA | — | Pending | Jan 17, 2024 |
| 18570611 | SUB-MICRON PARTICLE | Imperial College Innovations Limited | SHOMER, ISAAC | 1612 | Other | Non-Final OA | 12d | Pending | Dec 14, 2023 |
| 18537982 | SELF WARMING MEDICAL PRODUCTS, GELS, AND FLUIDS | Ldc Business Consulting LLC | OUYANG, BO | 3794 | §103 | Non-Final OA | 33d | Pending | Dec 13, 2023 |
| 18568728 | METHODS OF PROCESSING COLLAGEN FROM ANIMAL TISSUE | Grande Delta Corporation | JONES-FOSTER, ERICA NICOLE | 1656 | §103 | Final Rejection | — | Pending | Dec 08, 2023 |
| 18565072 | COPOLYMER, TREATMENT AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Beijing Mapu New Materials Co., Ltd. | LENIHAN, JEFFREY S | DP | Non-Final OA | — | Pending | Nov 28, 2023 | |
| 18559040 | USE OF CELLULAR MICROPARTICLES IN TREATMENT OF RESPIRATORY VIRAL PNEUMONIA | Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences | MIANO, JOSEPH PAUL | 1631 | §103 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18491581 | RIGID ENDOTRACHEAL INTUBATION STYLET | Sam Rx, Pllc | DITMER, KATHRYN ELIZABETH | 3785 | §102 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18484359 | METHODS OF INCREASING BIOMASS PRODUCTIVITY IN ALGAE CULTURES | Arizona Board of Regents | PAPCIAK, SHARON M | 1657 | Other | Final Rejection | 15d overdue | Pending | Oct 10, 2023 |
| 18554199 | THERAPEUTIC MODALITIES FOR INHIBITING PANCREATIC BETA CELL IMPAIRMENT AND TREATING DIABETES | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | HABTE, KAHSAY | 1624 | §112 | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18480489 | TEMPORAL TRAUMATIC BRAIN INJURY BIOMARKERS AND METHODS OF USE THEREOF | Arizona Board of Regents | NGUYEN, NAM P | 1678 | DP | Final Rejection | 43d overdue | Pending | Oct 03, 2023 |
| 18550037 | GENETICALLY-MODIFIED FILAMENTOUS FUNGI FOR PRODUCTION OF EXOGENOUS PROTEINS HAVING REDUCED OR NO N-LINKED GLYCOSYLATION | Dyadic International (Usa), Inc. | HAUK TEODORO, PRICILA NMN | 1645 | §103 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18362678 | IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECS) | Emmetrope Ophthalmics LLC | GABEL, GAILENE | 1678 | §102 | Non-Final OA | — | Pending | Jul 31, 2023 |
| 18350099 | 3,5-DIIODOTHYROPROPIONIC ACID COMPOSITIONS AND METHODS OF USE THEREOF | Dexcel Pharma Technologies Ltd. | HEES, OLIVER DRAGON | 1628 | Other | Non-Final OA | 49d overdue | Pending | Jul 11, 2023 |
| 18259538 | HUMAN PAPILLOMAVIRUS TYPE 18 CHIMERIC PROTEIN AND USE THEREOF | Institute Of Basic Medical Sciences, Chinese Academy Of Medical Sciences | BOESEN, AGNIESZKA | 1672 | §112 | Non-Final OA | — | Pending | Jun 27, 2023 |
| 18326837 | AUTOANTIBODIES, KITS AND METHODS OF VERIFYING THE ACCURACY OF DIAGNOSTIC RESULTS | Arizona Board of Regents | LIRIANO-NG, MELISSA LIZETTE | 1677 | §101 | Non-Final OA | 34d | Pending | May 31, 2023 |
| 18253916 | SMALL MOLECULE INHIBITOR FOR CATHEPSIN C AND MEDICINAL USE THEREOF | Reistone Biopharma Company Limited | HABTE, KAHSAY | 1624 | §112 | Non-Final OA | 17d overdue | Pending | May 22, 2023 |
| 18252171 | METHODS OF USING PLATELET FACTOR 4 AS AN ANTIMICROBIAL AGENT | Arizona Board of Regents | YANG, TIAN | 1674 | §103 | Non-Final OA | — | Pending | May 08, 2023 |
| 18251222 | A MULTI-SCAFFOLD SYSTEM FOR LARGE SCALE CULTIVATION OF CELLS | Aleph Farms Ltd. | MCGUIRK, JOHN SCHUYLER | 1798 | §103 | Final Rejection | 12d | Pending | Apr 28, 2023 |
| 18250136 | BATTERY RECYCLING | The University of Birmingham | DARBY, BRENDON CHARLES | 1749 | §103 | Non-Final OA | 22d | Pending | Apr 21, 2023 |
| 18249058 | LIPOPEPTIDE FUSION INHIBITORS AS SARS-COV-2 ANTIVIRALS | INSERM | BEANE, RANDALL L | 1654 | §103 | Final Rejection | 103d overdue | Pending | Apr 13, 2023 |
| 18298042 | MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF | The Trustees of Columbia University in the City of New York | ALAWADI, SARAH | 1619 | §102 | Non-Final OA | 34d | Pending | Apr 10, 2023 |
| 18121759 | USE OF ANTI-CRISPR AGENTS TO CONTROL EDITING IN HUMAN EMBRYOS | The Trustees of Columbia University in the City of New York | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Final Rejection | — | Pending | Mar 15, 2023 |
| 18041618 | NANOPARTICULATE SYSTEM FOR TREATING ORAL CANCER | The Trustees of Columbia University in the City of New York | KAMM, JUDITH MARIE | 1611 | §102 | Final Rejection | 110d overdue | Pending | Feb 14, 2023 |
| 18040810 | CELLULOSE BINDING DOMAIN (CBD) CELL EFFECTOR PROTEIN (CEP) CHIMERA, FOR THE TISSUE ENGINEERING | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | LEE, JAE W | 1656 | §103 | Non-Final OA | 15d | Pending | Feb 06, 2023 |
| 18012157 | METHOD FOR PRODUCING METAL AND/OR METALLOID COMPOUNDS IN AN IONIC LIQUID | Nanomox Ltd. | FIORITO, JAMES A | 1731 | §102 | Non-Final OA | 5d | Pending | Dec 21, 2022 |
| 17922315 | NEOANTIGEN-INFORMED TUMOR-INFILTRATING LYMPHOCYTE CANCER IMMUNOTHERAPY | The Translational Genomics Research Institute | VAN DRUFF, SYDNEY | 1643 | §103 | Non-Final OA | — | Pending | Oct 28, 2022 |
| 17996917 | LIPID-PEPTIDE FUSION INHIBITORS AS SARS-COV-2 ANTIVIRALS | Wisconsin Alumni Research Foundation | COFFA, SERGIO | 1658 | Other | Non-Final OA | 21d | Pending | Oct 21, 2022 |
| 17917339 | Compositions and Methods for the Prevention of Stress-Induced Fear, Depressive-Like and Anxiety- Like Behavior | The Research Foundation for Mental Hygiene, Inc. | VALENROD, YEVGENY | 1628 | §103 | Non-Final OA | — | Pending | Oct 06, 2022 |
| 17912486 | AUTOTHERMAL DIRECT AIR CAPTURE SYSTEM | Max Planck Gesselschaft Zur Foerderung Der Wissenschaft Ev | DIETERLE, JENNIFER M | 1776 | §103 | Non-Final OA | — | Pending | Sep 16, 2022 |
| 17911341 | METHODS AND KITS FOR THE DETECTION OF SARS-COV-2 | The Translational Genomics Research Institute | JADHAO, SAMADHAN JAISING | 1672 | §112 | Final Rejection | — | Pending | Sep 13, 2022 |
| 17911409 | BIO-BASED NYLON PRECURSORS HAVING REDUCED ORGANIC AND INORGANIC IMPURITIES | Mojia Biotech Ltd. | RAMIREZ, DELIA M | 1652 | §103 | Final Rejection | — | Pending | Sep 13, 2022 |
| 17905583 | IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING | The Trustees of Columbia University in the City of New York | LEE, JAE W | 1656 | §102 | Final Rejection | — | Pending | Sep 02, 2022 |
| 17887341 | SCALABLE AND FACILE CELL-MEMBRANE-COATING TECHNOLOGY FOR BOTH POSITIVELY AND NEGATIVELY CHARGED PARTICLES | The Trustees of Columbia University in the City of New York | PUTTLITZ, KARL J | 1646 | §103 | Final Rejection | 25d overdue | Pending | Aug 12, 2022 |
| 17793383 | METHODS OF IDENTIFYING SYNTHETIC MOLECULAR BINDING AGENTS | Arizona Board of Regents | BOESEN, CHRISTIAN C | 1684 | §103 | Non-Final OA | — | Pending | Jul 15, 2022 |
| 17848308 | SYSTEMS FOR CATALYTICALLY REMOVING PER- AND POLYFLUOROALKYL SUBSTANCES FROM A FLUID AND RELATED METHODS | Arizona Board of Regents | NORRIS, CLAIRE A | 1779 | §103 | Non-Final OA | — | Pending | Jun 23, 2022 |
| 17788285 | CELL POPULATION AND METHOD OF OBTAINING THE SAME | Reeir, Inc. | STAVROU, CONSTANTINA E | 1632 | §102 | Non-Final OA | 29d | Pending | Jun 22, 2022 |
| 17770962 | A TESTING SYSTEM | Safe Gauge Pty Ltd. | OLAMIT, JUSTIN N | 2853 | §103 | Non-Final OA | 118d overdue | Pending | Apr 21, 2022 |
| 17641786 | Methods and Apparatuses for Fabricating Polymeric Conformal Coatings, Parts Coated With Polymeric Conformal Coatings, and Optical Apparatus Including Said Parts | UCL Business Ltd | BOWMAN, ANDREW J | 1717 | §103 | Non-Final OA | 1d overdue | Pending | Mar 09, 2022 |
| 17640327 | COMBINATION ANTIVIRAL THERAPY FOR MEASLES | Cornell University | PARKIN, JEFFREY S | 1671 | §103 | Non-Final OA | — | Pending | Mar 03, 2022 |
| 17580219 | INCREASING GENOME STABILITY AND REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS | The Trustees of Columbia University in the City of New York | GRABER, JAMES J | 1631 | §103 | Final Rejection | — | Pending | Jan 20, 2022 |
| 17625333 | METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA | The Translational Genomics Research Institute | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Non-Final OA | — | Pending | Jan 06, 2022 |
| 17618869 | TARGETS AND METHODS OF DIAGNOSING, MONITORING AND TREATING FRONTOTEMPORAL DEMENTIA | Arizona Board of Regents | IVICH, FERNANDO NMN | 1678 | §112 | Final Rejection | 22d | Pending | Dec 13, 2021 |
| 17610863 | SYSTEMS AND METHODS FOR PHENOTYPING | Technion Research And Development Foundation Limited | CLOW, LORI A | 1687 | §103 | Final Rejection | 131d overdue | Pending | Nov 12, 2021 |
| 17494218 | PROPHYLACTIC EFFICACY OF SEROTONIN 4 RECEPTOR AGONISTS AGAINST STRESS | Institut National de la Santé et de la Recherche Médicale | BRAUN, MADELINE E | 1624 | §103 | Non-Final OA | — | Pending | Oct 05, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial